According to financial filings, AdvaMed spent $385,000 in the first quarter of 2010 lobbying Congress on behalf of the medtech industry. The organization's efforts were spurred by several significant issues. The first is healthcare reform, which dominated headlines for months. Another is federal preemption—AdvaMed sought to keep federal law that protects device makers from being sued in personal injury lawsuits from being overturned by Congress. Finally, AdvaMed lobbied to protect the 510(k) clearance program, which if overhauled could make it harder to get new devices on the market in a cost-efficient manner, the group says.